Dendritic cells and the control of immunity

Nature

Volumn 392, Issue 6673, 1998, Pages 245-252

  Banchereau, Jacques ^a   Steinman, Ralph M ^b  

^a BAYLOR RESEARCH INSTITUTE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; B LYMPHOCYTE ACTIVATION; CELL INTERACTION; DENDRITIC CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MOVEMENT; DENDRITIC CELLS; FORECASTING; HUMANS; IMMUNITY; SELF TOLERANCE; T-LYMPHOCYTES;

EID: 0032546352     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/32588     Document Type: Review

References (103)

1. Steinman, R. M. in Fundamental Immunology (ed. Paul, W. E.) 4th edn (Lippincott-Raven, Philadelphia, in the press).
2. Inaba, K. et al. Generation of large numbers of dendrítíc cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176. 1693-1720 (1992).
3. Caux, C., Dezutter-Dambuyant, C, Schmitt, D. & Banchereau, J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360, 256-261 (1992).
4. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimluating factor, and TNF-α. J. Immunol. 154, 5851-5861 (1995).
5. Romani, N. et al. Proliferating dendritic cell progenitors in human blood, J. Exp. Med. 180, 83-93 (1994).
6. Sallusto, F. & Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109-1118 (1994).
7. Salluitu, F. & Lanzavecchia, A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate antigen to the MHC class II compartment. Downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400 (1995).
8. Romani, N. et al. Generation of mature dendritic cell from human blood: An improved method with special regard to clinical applicability. J. Immunol. Meth. 196, 137-151 (1996).
9. Reddy, A., Sapp, M., Feldman, M., Subklewe, M. & Bhardwaj, N.A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Bllod 90, 3640-3646 (1997).
10. Maraskovsky, E. et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 and ligand-treated mice: Multiple dendritic cell subpopulations identified. J. Exp. Med. 184, 1953-1962 (1996).
11. Adema, G. J. et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Mature 387, 713-717 (1997).
12. Mueller, C. G. F. et al. Polymerase chain reaction selects a novel disintegrin-proteinase from CD40activated germinal center dendritic cells. J. Exp. Med. 186, 655-663 (1997).
13. Greaves, D. R. et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3α and is highly expressed in human dendritic cells. J. Exp. Med. 196, 837-844 (1997).
14. Winzler, C, et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185, 317-328 (1997).
15. Bhtrdwaj, N., Young, J. W., Nisanian, A. J., Baggers, J. & Steinman, R. M. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses. J. Exp. Med. 178, 633-642 (1993).
16. Inaba, K., Inaba, M., Naito, M. & Steinman, R. M. Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178, 479-488 (1993).
17. Moll, H., Fuchs, H., Blank, C. & Rollinghoff, M. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur. J. Immunol. 23, 1595-1601 (1993).
18. Zitvogel, L. et al. Therapy of murine tumors with tumor peptide pulsed dendritic cells: Dependence on T-celis, B7 costimulation, and Thl-associated cytokines. J. Exp. Med. 183, 87-97 (1996).
19. Paglia, P., Chiodoni, C., Rodolfo, M. & Colombo, M. P. Murine dendritic cells loaded in vitro with soluble protein prime CTL against tumor antigen in vivo. J. Exp. Med. 183, 317-322 (1996).
20. Mayordomo, J. I. et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med 1, 1297-1302 (1995).
21. Hsu, F. J. et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2, 52-58 (1996).
22. + T cells. J. Exp. Med. 185, 2133-2141 (1997).
23. Luther, S. A., Gulbranson-Judge, A., Acha-Orbea, H. & Maclennan, I. C. M. Viral superantigen drives extrafollicular and follicular B differentiation leading to virus-specific antibody production. J. Exp. Med. 185, 551-562 (1997).
24. Kudo, S., Matsuno, K., Ezaki, T. & Ogawa, M. A novel migration pathway for rat dendritic cells from the blood: Hepatic sinusoids-lymph translocation. J. Exp. Med. 185, 777-784 (1997).
25. Inaba, K. et al. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from lymph node. J. Exp. Med. 186, 665-672 (1997).
26. Cella, M. et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184, 747-752 (1996).
27. Koch, F. et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184, 741-747 (1996).
28. Reis e Sousa, C. et al. In vivo microbial stimulation induces rapid CD40L-independent production of IL-12 by dendritic cells and their re-distribution to T cell areas. J. Exp. Med. 186, 1819-1829 (1997).
29. Caux, C. et al. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180, 1841-1847 (1994).
30. Inaba, K. et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180, 1849-1860 (1994).
31. + T cells. J. Clin. Invest. 94, 797-807 (1994).
32. 8+ cytolytic T cell responses. J. Exp. Med. 182, 1663-1671 (1995).
33. Caux, C. et al. Activation of human dendritic cells through CD40 crou-linking. J. Exp. Med. 180, 1263-3272(1994).
34. Wong, B. R. et al. TRANCE, a new TNF family member predominantly expressed in T cells, is a dendritic cell specific survival factor. J. Exp. Med. 186, 2075-2080 (1997).
35. Anderson, D. M. et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179 (1997).
36. Lukas, M. et al. Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. J. Invest. Dermatol. 106, 1293-1299 (1996).
37. Reis e Sousa, C., Stahl, P. D. & Austyn, J. M. Phagocytosis of antigens by Langerhans cells in vitro. J. Exp. Med. 178, 509-519 (1993).
38. Svensson, M., Stockinger, B. & Wick, M. J. Bone marrow-derived dendritic cells can process bacteria for MHC-1 and MHC-II presentation to T cells. J. Immunol. 158, 4229-4236 (1997).
39. Jiang, W. et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375, 151-155 (1995).
40. Nijinan, H. W. et al. Antigen capture and MHC class II compartments of freshly isolated and cultured human blood dendritic cells. J. Exp. Med. 182, 163-174 (1995).
41. Pierre, P. et al. Developmental regulation of MHC class II transport in mouse dendritic cells, Nature 388, 787-792 (1997).
42. Cella, M., Engering, A., Pinet, V., Pieters, J. & Lanzavecchia, A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782-787 (1997).
43. s. Nature 392, 66-89 (1998).
44. Buelens, C. et al. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by IL-10. Eur. J. Immunol. 27, 1848-1852 (1997).
45. Sallusto, F., Nicolo, C., De Maria, R., Curinti, S. & Testi, R. Ceramide inhibits antigen uptake and presentation by dendritic cells. J. Exp. Med. 184, 2411-2416 (1996).
46. Granelli-Piperno, A., Pope, M., Inaba, K. & Steinman, R. M. Coexpression of REL and SP1 transcription factors in HIV-1 induced, dendritic cell-T cell syncytia. Proc. Natl Acad. Sci. USA 92, 1094-10948 (1995).
47. Kitajima, T., Arizumi, K., Bergstresser, P. R. & Takashima, A. A novel mechanism of glucocorticoid-induced immune suppression: The inhibition of T cell-mediated terminal maturation of a murine dendritic cell line, J. Clin. Invest. 98, 142-147 (1996).
48. Brocker, T. Survival of mature CD4 T lymphocytes is dependent on MHC class II expressing dendritic cells. J. Exp. Med. 186, 1223-1232 (1997).
49. O'Doherty, U. et al. Human blood contains two subsets of dendritic cells, one immunologically mature, and the other immature, Immunology 82, 487-493 (1994).
50. Brown, K. A. et al. Human blood dendritic cells: binding to vascular endothelium and expression of adhesion molecules. Clin. Exp. Immunol. 107, 601-607 (1997).
51. Matsuno, K., Huki, T., Kudo, S. & Uehara, Y. A life stage of particle-laden rat dendritk cells in vivo: their terminal division, active phagocytosis and translocation from the liver to hectic lymph. J. Exp. Med. 183, 1865-1878 (1996).
52. McWilIiam, A. S. et al. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli, J. Exp. Med. 184, 2429-2432 (1996).
53. Roake, J. A. et al. Dendritic cell loss from non-lymphoid tissues following systemic administration of lipopolysaccharide, tumour necrosis factor, and interleukin-1. J. Exp. Med. 181, 2237-2248 (1995).
54. MacPheraon, G. G., Jenkins. C. D. Stein, M. J. & Edwards, C. Endotoxin-mediated dendritic cell release from the intestine: Characterization of released dendritic cells and TNF dependence. J. Immunol 154, 1317-1322 (1995).
55. De Smedt, T. et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 184, 1413-1424 (1996).
56. Hosoi, J. et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363, 159-162 (1993).
57. Sozzani, S. et al. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 155, 3292-3295 (1995).
58. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α, J. Exp. Med. 182, 1111-1120 (1995).
59. Saunders, D. et al Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 184, 2185-2196 (1996).
60. + hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J. Exp. Med. 185, 341-349 (1997).
61. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+ TNFα. J. Exp. Med. 184, 695-706 (1996).
62. Strunk, D., Egger, C, Leitner, G., Hanau, D. & Stingl, G. A skin homing molecule defines the Langerhans cells progenitor in human peripheral blood. J. Exp. Med. 185, 1131-1136 (1997).
63. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNFα: II Functional analysis. Blood 90, 1458-1470 (1997).
64. Szabolcs, P. et al. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-CFU intermediate. Blood 87, 4520-4530 (1996).
65. Borkowski, T. A., Letterio, I. J., Fan, A. G. & Udey, M. C. A role for endogenous transforming growth factor βl in Langerhans cell biology: The skin of transforming growth factor βl null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184, 2417-2422 (1996).
66. Suss, G. & Shortman, K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand induced apoptosis. J. Exp. Med. 183, 1789-1796 (1996).
67. Ardavin, C., Wu, L., Li, C. & Shortman, K. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature 362, 761-763 (1993).
68. Grouard, G, et al. The enigmatic plasmacytoid T cells develop into dendritic cells with IL-3 and CD40-ligand. J. Exp. Med. 185, 1101-1111 (1997).
69. Lieberman, P. H. et al. Langerhans cell [eosinophilic] granulomatosis. A clinicopathologic study encompassing 50 years. Am. J. Surg. Pathol 20, 519-552 (1996).
70. Dubois, B. et al. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185, 941-951 (1997).
71. Fayette, J. et al. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J. Exp. Med. 185, 1909-1918 (1997).
72. Frankel, S. S. et al. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid, Science 272, 115-117 (1996).
73. Frankel, S. S. et al. Active replication of HIV-1 at the lymphoepithelial surface of the tonsil. Am. J. Pathol. 151, 89-96 (1997).
74. Kelsall, B. L. & Strober, W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's Patch. J. Exp. Med. 183, 237-247 (1996).
75. Matsumoto, M. et al. Distinct roles of lymphotoxin-α and type 1 TNF receptor in the establishment of follicular dendritic cells from non-bone marrow-derived cells. J. Exp. Med. 186, 1997-2004 (1997).
76. Liu, Y.-J., Grouard, G., de Bouteiller, O. & Banchereau, J. Follicular dendritic cells and germinal centers. Int. Rev. Cytology 166, 139-179 (1996).
77. Liu, Y.-J. et al. Follicular dendritic cells specifically express the long CR2/CD21 isoform. J. Exp. Med. 185, 165-170 (1997).
78. Grouard, G., Durand, I., Filgueira, L., Banchereau, J. & Liu Y.-J. Dendritic cells capable of stimulating T cells in germinal centres. Nature 384, 364-367 (1996).
79. Brocker, T. & Karjalainen, K. Targeted expression of MHC class II molecules demonstrates that dendritic cells can induce negative but no positive selection of thymocytes in vivo. J. Exp. Med. 185, 541-550 (1997).
80. Laufer, T. M., DeKoning, I., Markowitz, J, S., Lo, D. & Glimcher, L. H. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 383, 81-85 (1996).
81. Zal, T., Volkmann, A. & Stockinger, B. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180, 2089-2099 (1994).
82. Kurts, C. et al. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184, 923-930 (1996).
83. Kurts, C., Kosaka, H., Carbone, F. R., Miller, T. F. A. P. & Heath, W. R. Class I-restricted cross- presentation of exogenous self antigens leads to deletion of autoreactivc CD8+ T cells. J. Exp. Med. 186, 239-245 (1997).
84. Forster, I. & Lieberam, I. Peripheral tolerance of CD4 T cells following local activation in adolescent mice. Eur. J. Immunol. 26, 3194-3202 (1996).
85. Soderberg-Naucler, C., Fish, K. N. & Nelson, J. A. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91, 119-126 (1997).
86. Rettig, M. B. et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 276, 1851-1854 (1997).
87. + T cells. Science 257, 383-337 (1992).
88. + T cells is markedly enhanced in the setting of antigen-specific immune activation. J. Exp. Med. 183, 687-692 (1996).
89. Pinchuk, L. M., Policino, P. S., Agy, M. B., Klaus, S. J. & Clark, E. A. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1, 317-325 (1994).
90. Pope, M, et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78, 389-398 (1994).
91. + T cells. J. Exp. Med. 186, 801-812 (1997).
92. Schnorr, J.-J. et al. Induction of maturation of human blood dendritic cell precursors by measles virus Is associated with immunosuppression. Proc. Natl Acad. Sci. USA 94, 5326-531 (1997).
93. Fugier-Vivier, I. et al. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186, 813-823 (1997).
94. Pope, M., Elmore, D., Ho, D. & Marx, P. Dendritic cell-T cell mixtures, isolated from the skin and mucosae of macaques, support the replication of SIV. AIDS Res. Hum, Retro. 13, 819-827 (1997).
95. Chaux, P., Moutet, M., Faivre, I., Martin, F. & Martin, M. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 constimulatory molecules of the T-cell activation. Lab. Invest. 74, 975-983 (1996).
96. Specht, J. M. et al. Dendritic cells retrovirally transduced with a model tumor antigen gene are therapeutically effective against established pulmonary metastates. J. Exp. Med. 186, 1213-1221 (1997).
97. Song, W, et al. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model tumor antigen induce protective and therapeutic antitumor immunity. J. Exp. Med. 186, 1247-1256 (1997).
98. Schuler, G. & Steinman, R. M. Dendritic cells as adjuvants for immune-mediated resiatance to tumors. J. Exp. Med. 186, 1183-1187 (1997).
99. 2+-dependent mechanism. J. Exp. Med. 186, 467-472 (1997).
100. Condon, C., Watkins, S. C., Celluzzi, C. M., Thompson, K. & Falo, L. D. Jr DNA-based immunization by in vivo transfection of dendritic cells. Nature Med. 2, 1122-1128 (1996).
101. Casares, S., Inaba, K., Brumeanu, T., Steinman, R, M. & Bona, C. A. Antigen presentation by dendritic cells following immunization with DNA encoding a class II-restricted viral epitope. J. Exp. Med. 186, 1481-1486 (1997).
102. Colonna, M. et al. A commun inhibitory receptor for MHC class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186, 1809-1818 (1997).
103. Vicari, A. P. et al. TECK: A novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. Immunity 7, 291-302 (1997).